DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1ALTOPREV
02 6BUDESONIDE
03 1CARDIZEM CD
04 1CARTIA XT
05 2DEXMETHYLPHENIDATE HYDROCHLORIDE
06 2DILTIAZEM HYDROCHLORIDE
07 1DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
08 1ENTOCORT EC
09 1FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
10 2GLIPIZIDE
11 1KLOR-CON M10
12 1KLOR-CON M15
13 1KLOR-CON M20
14 3METHYLPHENIDATE HYDROCHLORIDE
15 5METOPROLOL SUCCINATE
16 1ORTIKOS
17 1POTASSIUM CHLORIDE
18 1SOLUPREP S
19 1TOPROL-XL
01 119962
02 120062
03 121316
04 121324
05 374726
06 174752
07 175604
08 176467
09 178458
10 178889
11 179043
12 179108
13 190379
14 190410
15 190492
16 190617
17 1200886
18 1202975
19 1203614
20 1204161
21 1206134
22 1206534
23 1206623
24 1206724
25 1206928
26 1207367
27 1207465
28 1208288
29 1211796
30 1211929
31 1216916
01 32No
02 1Yes
Drug : BUDESONIDE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 206623
Country : US
Patented : No
Drug : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 78458
Country : US
Patented : No
Drug : METOPROLOL SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 78889
Country : US
Patented : No
Drug : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 200886
Country : US
Patented : No
Drug : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 211796
Country : US
Patented : No
Drug : METOPROLOL SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 216916
Country : US
Patented : No
Drug : ALTOPREV
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 21316
Country : US
Patented : No
Drug : BUDESONIDE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 207367
Country : US
Patented : No
Drug : BUDESONIDE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 206134
Country : US
Patented : No
Drug : DILTIAZEM HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 206534
Country : US
Patented : No
LOOKING FOR A SUPPLIER?